Month: July 2020

TORONTO, July 14, 2020 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) will announce its 2020 second quarter results on August 12, 2020 prior to market open. The Company will also host its earnings conference call the same day at 8:30 a.m. EDT. The call will be hosted by CEO Geoffrey Benic and CFO Benjamin Ferdinand.CONFERENCE CALL & WEBCASTDate: August 12, 2020Time: 8:30 a.m. EDTUSA/Canada Toll-Free Participant Call-in: (866) 679-9046; Passcode: 4391846International Toll-Free Participant Call-in: (409) 217-8323; Passcode: 4391846WEBCAST LINKThis conference call will be webcast live over the internet and can be accessed through the link provided. Audio of the call will be available to participants through both the conference call line and webcast; however, the presentation may...

VANCOUVER, British Columbia, July 14, 2020 (GLOBE NEWSWIRE) — Marimaca Copper Corp. (“Marimaca Copper” or the “Company”) (TSX: MARI) is pleased to announce the results of a high resolution, drone mounted, magnetic survey at the Company’s flagship Marimaca Copper Project (“Marimaca” or “the Project”) in Chile. This work follows on from the updated geological interpretation for Marimaca (refer to release 8 June 2020), which indicates strong potential for sulphide mineralization beneath the Marimaca Oxide Deposit (“MOD”).HighlightsLarge magnetic anomaly, which provides a copper sulphide target for follow-up exploration, located underneath the MOD, within the interpreted extensions of the same structures that host copper mineralization at surface— Total volume of the favourable magnetic anomaly is approximately 175 million cubic metres— Equivalent...

SAN MATEO, Calif., July 14, 2020 (GLOBE NEWSWIRE) — Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the “Company” or “PLUS”), a cannabis and hemp branded products company in the U.S., today announced the launch of its new HI-CUBES brand into the California adult-use market.HighlightsMost concentrated gummy product (THC by volume) available in the California market.1100% whole plant, full-spectrum oil delivers cannabinoids, flavonoids and aromatic terpenes for a more dynamic high.Great tasting and guilt-free: only 5 calories and less than 1g of sugar per cube.New line-up will initially include two high THC gummy products specifically formulated for cannabis users looking for a stronger psychoactive effect.             HI-CUBES is the third edibles brand launched by PLUS, well known for its core brand of high-quality and precisely...

MIAMI, July 14, 2020 (GLOBE NEWSWIRE) — Watsco, Inc. (NYSE: WSO) announced today that it will host a conference call to discuss its 2020 second quarter financial results on Thursday, July 23, 2020 at 10:00 a.m. (EDT). Prepared remarks regarding the results will be followed by a question and answer session with the senior management team.The conference call will be web-cast by CCBN’s StreetEvents and can be found under the link highlighted on our website at http://www.watsco.com. The earnings results will be released before the market opens on July 23, 2020. A replay of the conference call will be available on our website.Investors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will be given a unique PIN to gain immediate access to the call. Pre-registration...

— BOLD is first-ever pivotal trial for biliary atresia —— Trial expands odevixibat’s development program into second rare cholestatic liver disease —BOSTON, July 14, 2020 (GLOBE NEWSWIRE) —  Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the first patient has been enrolled in the BOLD (Biliary atresia and the use of Odevixibat in treating Liver Disease) global Phase 3 clinical trial of odevixibat, a highly potent and selective inhibitor of the ileal bile acid transporter (IBAT), for the treatment of biliary atresia. There are no approved pharmacological treatments for biliary atresia which is the most common pediatric cholestatic liver disease and the leading cause of pediatric liver transplant across all diseases.  BOLD is the largest,...

DALLAS, July 14, 2020 (GLOBE NEWSWIRE) — Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented manufacturing and marketing company focused on employing FDA-approved Metered Dose Inhaler (MDI) technology to deliver aerosolized cannabinoids, such as CBD, CBG, and THC, announced today that it has delivered an additional 6,000 units (8,000 total) under its previously announced 100,000 unit order that was recently expanded to 250,000 units.The Company has leased a state-of-the-art lab tested to ISO 6 standards and maintains general facility/process controls in its environmentally filtered operations, as part of compliance with FDA Good Manufacturing Practices (GMP) related to ISO 13485.  This lab will allow the company to pursue RTSL’s stated goal of FDA registration of all RTSL products.Rapid...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S.TORONTO, July 14, 2020 (GLOBE NEWSWIRE) — G2 Goldfields Inc. (TSXV: GTWO) (the “Company” or “G2”) is pleased to announce multiple high-grade drilling intercepts from the Company’s ongoing drilling program at the 19,200-acre Oko-Aremu property, Region 7, Guyana.  The Company has completed 63 diamond drill holes to date, totalling 13,971 metres.  Drilling has demonstrated that within the Oko mine area high-grade gold mineralization is hosted in (i) shallow north plunging hinge zones, and (ii) in steeply dipping limbs of tightly folded carbonaceous sediments.Highlights of recent drilling in the main Oko zone include 17.8 g/t Au over 2.5 m (OKD – 46), 9.5 g/t Au over 4.4 m (OKD – 47), as well as 21.1 g/t Au over 2.1 m and 26.1 g/t Au over 1.6 m (OKD – 48). ...

$250 Million in Committed Capital to Cytokinetics;Additional $200 Million in Development and Commercialization Milestone PaymentsJi Xing Pharmaceuticals to Develop & Commercialize in ChinaRTW Provides Access to Capital to Cytokineticsto Fund Global Development in Exchange for Potential Royaltiesand Agrees to Purchase Royalty on MavacamtenCompany to Host Conference Call and Webcast Today at 8:30 am Eastern TimeSOUTH SAN FRANCISCO, Calif., July 14, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it has agreed to a series of transactions with certain companies wholly owned by investment funds managed by RTW Investments, LP, and Ji Xing Pharmaceuticals Limited (“Ji Xing”), related to CK-3773274 (“CK-274”), a next-generation cardiac myosin inhibitor that Cytokinetics is developing for the potential...

Lækkun hlutafjár Eikar fasteignafélags hf. um 41.317.000 kr. að nafnverði hefur verið skráð í fyrirtækjaskrá. Lækkunin var samþykkt á aðalfundi félagsins 10. júní 2020 og tók aðeins til eigin hluta.Hlutafé félagsins er nú 3.423.863.435 kr. að nafnverði en var fyrir lækkun 3.465.180.435 kr. að nafnverði. Hver hlutur er ein króna að nafnverði. Allir hlutir eru í sama flokki og njóta sömu réttinda.